Skip to main content
. 2015 Jul 14;6(26):23026–23035. doi: 10.18632/oncotarget.4854

Table 3. Subgroups of primary melanoma in training cohort, validation cohort and combined cohort.

Population Subgroup Expression Case no. (%)
Training cohort (145 cases) ML KAI1-/P27- 48 (33.10)
NML Either KAI1 or p27 is negative 97 (66.90)
Validation cohort (92 cases) ML KAI1- P27- 34 (37.00)
NML Either KAI1 or p27 is negative 58 (63.00)
Combined cohort (237 cases) ML KAI1- P27- 82 (34.60)
NML Either KAI1 or p27 is negative 155 (65.40)

ML, metastasis-like; NML, non-metastasis-like